Back to search
FDAFDA · Food and drugs·Recall number D-0830-2018

PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 15 mg, Rx Only, 48-count bottle, NDC 00378-4715-22

Published May 30, 2018 · Recall initiated: April 30, 2018

Summary

FDA records drug Class II recall D-0830-2018, published May 30, 2018 and initiated April 30, 2018. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 9,906 48-count bottles; Lot: Lot #: 3082509; Exp. 08/18 3085901; Exp. 12/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Recalling firm distributed product to wholesalers throughout the United States, including Puerto Rico.
Lot
Lot #: 3082509; Exp. 08/18 3085901; Exp. 12/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 15 mg, Rx Only, 48-count bottle, NDC 00378-4715-22 recalled?

Yes. FDA published recall D-0830-2018 on May 30, 2018. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter